Previous TCGA-based analyses suggest that glucose and acetate are preferential substrates in IDH wild-type, rather than IDH-mutant gliomas [20]; therefore, the relative contribution of glucose and acetate in clinical IDH-mutant gliomas needs further investigations. This evidence concerns the gene IDH1 and central nervous system cancer.